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The alkaline single-cell gel electrophoresis (or comet) assay was applied to evaluate the 
eventual DNA damage induced by the triphenolic metabolite of benzene, 1,2,4-
benzenetriol (BT), in isolated human lymphocytes. Prior to BT treatment, ranging from 5–
50 μM, a supplementation with glutathione (GSH, 350 μg/ml) was carried out to assess 
whether GSH may have a modulating effect on the comet response. The effect of a fixed 
dose of BT was also evaluated in the presence of the exogenous antioxidant vitamin C 
(40 and 200 μM). Additionally, we investigated whether the polymorphism of glutathione 
S-transferase T1 (GSTT1) gene may affect the individual level of BT-induced DNA 
damage in vitro. For all donors included in the present study, BT produced a significant 
dose-response relationship. No clear effect of GSH preincubation was seen on the BT-
induced response. On the contrary, a significant reduction of DNA damage was observed 
in the presence of vitamin C (at least at 200 μM). Although our data suggest some 
individual differences according to the GSTT1 genotype in the outcome of the comet 
assay, a large number of individuals should be studied in further investigations to obtain 
reliable conclusions. 
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INTRODUCTION 
Benzene is a well-known promutagen and benzene metabolites are responsible not only for its 
genotoxicity, but also for its myelotoxicity and leukemogenesis[1,2]. The majority of benzene metabolism 
occurs in the liver, where cytochrome P4502E1 catalyzes the first step leading to the formation of phenol 
and other subsequent metabolites as cathecol, hydroquinone, and benzenetriol (BT). In addition, it has 
also been demonstrated that secondary metabolism of benzene metabolites in bone marrow critically 
contributes to benzene toxicity. The phenolic metabolites and muconic acid accumulate in the bone 
marrow, where myeloperoxidases may further convert them to their corresponding quinone and 
semiquinone radicals[3,4,5]. These can covalently bind to DNA and other cellular macromolecules, and 
are generally believed to be the ultimate toxic and genotoxic species. 
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BT, a minor and highly unstable triphenolic metabolite of benzene, has a strong ability to bind 
transition metal ions and rapidly autoxidizes to 2-hydroxy-1,4-benzoquinone and its semiquinone radical 
intermediates. Moreover, during this process, the products of BT oxidation have the potential to undergo 
cyclic reduction and oxidation reactions (redox cycling) that generate large amounts of reactive oxygen 
species, including superoxide anion (O2−), hydrogen peroxide (H2O2), and hydroxyl radical (OH•), as well 
as perhaps singlet oxygen (•O2). These reactive species are known to damage DNA and other cellular 
macromolecules[6,7,8]. Thus, oxidative mechanisms leading to a broad spectrum of DNA 
damage[9,10,11], as well as quinones-related microtubule disruption[12,13,14], have been reported as 
different pathways for the induction of genetic damage by BT. 
DNA damage due to the attack of free radicals or the action of electrophiles may be affected by GSH, 
which may play an important role in antimutagenesis and anticarcinogenesis as a free radical 
scavenger[15]. GSH along with the multigene family of phase II detoxifying enzymes, glutathione S-
transferases (GST), are assumed to constitute one of the more important systems that prevent mutagenic 
elctrophiles from being carcinogenic[16]. 
GSTs catalyze reactions of GSH with different exogenous electrophilic substrates and the GSH 
conjugates formed are usually nontoxic excretory products. By means of their GSH peroxidase activity, 
these enzymes also detoxify endogenous lipid and DNA hydroperoxides arising from oxidative 
damage[16,17,18]. It is known that some polyaromatic hydrocarbons, benzene metabolites, and their 
oxidation products may covalently bind to GSH and form nontoxic GSH conjugates[1,19]. Thus, genetic 
polymorphisms of GST and other xenobiotic-metabolizing enzymes that may influence the individual 
ability to activate or detoxify different benzene metabolites, including BT and its highly reactive quinone 
and semiquinone radicals, might possibly affect the amount of genetic damage formed and thereby 
modulate the susceptibility to benzene-induced mielotoxicity and leukemia[20]. 
Vitamin C can modify responses to oxygen radicals, acting under different conditions as either a 
radical scavenger or a pro-oxidant, producing hydrogen peroxide and free radicals by autoxidation[21,22]. 
A protective effect against oxidative damage and benzo(α)pyrene was observed in human lymphocytes 
both after in vitro and in vivo treatments[23,24,25]. 
The alkaline single-cell gel electrophoresis (or comet) assay (SCGE or CA) has been demonstrated to 
be a very sensitive method for measuring DNA single strand breaks and alkali-labile sites at the 
individual cell level[26,27]. This method previously revealed significant responses in human lymphocytes 
after in vitro treatments with BT and other benzene metabolites[28,29]. Using the same type of cells, the 
CA was applied to assess the modulating or protective effect of both GSH and vitamin C on BT 
genotoxicity, taking also into account the possible influence of GSTT1 genotype. 
MATERIALS AND METHODS 
Blood Donors, Lymphocyte Isolation, and Genotype Analyses 
Seven young men were used in the present study as blood donors. All of them were nonsmoking healthy 
people and ranged in age from 19–27 years. Prior to the CA experiments, genomic DNA extracted from 
leukocytes by standard methods was used as a template in the GSTT1 genotype analyses described 
elsewere[30]. Heparinized venous blood samples were drawn from each donor and lymphocytes were 
isolated immediately using a Ficoll density gradient. Approximately 15 ml of whole blood was diluted 
(1:1) with phosphate buffered saline (PBS) and centrifuged over 15 ml of lymphocyte isolation medium 
(Rafer, Zaragoza, Spain) at 800 g for 30 min. Buffy coat was removed and washed twice with PBS at 400 
g for 10 min, then the cells were resuspended in RPMI 1640 medium (Gibco BRL, Paisley, Scotland, 
U.K.) and counted in a hemocytometer. 




Isolated lymphocytes (106 cells/ml) were dispensed to Eppendorf tubes in RPMI 1640 medium without 
serum. In experiment 1, lymphocyte samples were preincubated at 37ºC for 30 min, with and without 
GSH (350 μg/ml). After this, appropriate volumes of BT were added to attain 5, 10, 25, and 50 μM 
concentrations. In experiment 2, lymphocytes were first incubated with vitamin C (0, 40, or 200 μM) at 
37ºC for 30 min, and a subsequent treatment with BT (25 μM) was carried out. In both experiments, 
treatments were done for 30 min at 37ºC and H2O2 (20 μM) was used as positive control. After treatment, 
cells were washed with PBS, centrifuged, and the pellet was resuspended in PBS. 
Single-Cell Gel Electrophoresis 
The CA was performed under alkaline conditions, basically as described by Singh et al.[31]. In brief, 80 
μl of 0.7% low-melting-point agarose (LMA in Ca2+-Mg2+-free PBS at pH 7.4, 37ºC), containing about 2 
× 105 cells, were pipetted onto a roughened slide precoated with a 125-μl layer of 1% normal-melting-
point agarose (NMA). The agarose was allowed to set on ice for 5 min. A third layer of 80 μl of LMA 
was applied and solidified again on ice. After removal of the coverslip, the slides were immersed in 
freshly prepared lysing solution (2.5 M NaCl, 100 mM Na2EDTA, 10 mM Tris-HCl, pH 10, with 1% 
Triton X-100 added just before use) for a minimum of 1 h at 4ºC after which they were placed in a 
horizontal electrophoresis tank in an ice bath. The tank was filled with freshly made alkaline buffer (1 
mM Na2EDTA, 300 mM NaOH, pH 13), and the slides were left in the high-pH buffer for 20 min to allow 
DNA unwinding and expression of alkali-labile sites. Electrophoresis was carried out for 20 min at 25 V 
and 300 mA in the dark. The slides were then neutralized by adding dropwise 0.4 M Tris-HCl (pH 7.5, 
washed three times for 5 min each). 
We purchased BT and GSH from Aldrich Chemical Co. Ltd. (Gillingham-Dorset, U.K.), and PBS 
tablets and vitamin C from Sigma Chemical Co. (St. Louis, MO). Fetal calf serum, NMA, and LMA were 
obtained from Gibco BRL. 
Staining and Slide Scoring 
The slides were stained with 60 μl of a 4’,6-diamidino-2-phenylindole dihydrochloride (DAPI) solution at 
a concentration of 5 and 0.2 μg/ml, for experiments 1 and 2, respectively. The slides were kept in a 
humidified chamber until scoring. 
In experiment 1, the slides were examined by eye using an Olympus BX50 fluorescence microscope 
equipped with a wide-band excitation filter of 330–385 nm and a barrier filter of 420 nm. One hundred 
cells (50 per replicate) were scored at 400× magnification, and the mean comet length was calculated for 
each concentration. Moreover, cells were graded by eye into five categories (A–E) according to the 
amount of DNA in the tail[23], where A are undamaged cells and E highly damaged cells. From the 
arbitrary values assigned to the different categories (from A = 0 to E = 4), a genetic damage index (GDI) 
was calculated. 
In experiment 2, the slides were examined using a Komet 3.1 image analysis system (Kinetic Imaging 
Ltd., Liverpool, U.K.). One hundred cells (50 per replicate) were scored for each concentration, and the 
mean tail moment (TM) and the percentage of DNA in the tail (%TDNA) were measured as DNA 
damage parameters. 
Statistical Analysis 
In all cases, significant correlation coefficients (r > 0.900; p < 0.001) were found between comet length 
and GDI, and also between TM and %TDNA (data not shown). For all donors included in this study, the 
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significance of the dose-response relationship was evaluated by means of a regression analysis, and CA 
values obtained from each BT treatment were compared with its negative control by means of the 
nonparametric Mann-Whitney U test. The same test was used to assess the possible modulating effect of 
both GSH and vitamin C, comparing DNA damage results between preincubated lymphocytes and their 
parallel cultures with neither GSH nor vitamin C supplementation. P values lower than 0.05 were 
regarded as statistically significant. The results were analyzed using the CSS: STATISTICA/WTM 
(StatSoft, Tulsa, OK) statistical package. 
RESULTS 
The characteristics of the donors included in the present investigation are summarized in Table 1. These 
individuals were selected from a larger group of potential donors according to health status, smoking 
habits, and GSTT1 genotype. 
TABLE 1 
Blood Donors Included in the Present Study 
Donor Age GSTT1 Experiment 1, BT + GSH 
Experiment 2, 
BT + Vit C 
A 19 + Yes Yes 
B 20 + Yes − 
C 27 + Yes Yes 
D 20 Null Yes Yes 
E 19 Null Yes Yes 
F 20 Null Yes − 
G 26 + − Yes 
As can be seen in Table 2, a statistically significant dose-response relationship was observed for the 
six donors included in the experiment 1, and Fig. 1 shows the mean comet length values obtained from 
each treatment. Both in the absence and presence of GSH, BT significantly induced DNA damage. In 
some donors, this increase could be detected even at the lowest doses tested (5 and 10 μM). An important 
variability for the magnitude of the test outcome was observed between the different donors, some of 
them (B and C) being more affected by BT treatments than others (D and E).  
Although a slight trend towards the reduction of BT-induced DNA damage was observed when 
preincubating lymphocytes with GSH (mainly in donors C, D, and E), the possible modulating effect of 
GSH was not clearly revealed using the CA. When tested alone at a concentration of 350 μg/ml, GSH 
failed to induce DNA damage. 
In the same experiment, when cells were pooled according to the GSTT1 genotype, GSTT1 + donors 
apparently showed to be more sensitive than GSTT1 null donors to in vitro BT effects, both in the absence 
and presence of GSH (Fig. 2). 
The response to a fixed concentration of BT (25 μM) or H2O2 (20 μM), in combination with different 
concentrations of vitamin C, was evaluated using the CA in experiment 2. The mean TM values for all 
donors are showed in Fig. 3. The clear BT and H2O2 positive results obtained in this second experiment 
confirmed those previously obtained when scoring by eye. Between the different donors, there were some 
differences in the degree of DNA damage induced by BT and H2O2, being the lymphocytes from 
individuals C and G those most affected by treatments.  




Regression Coefficients (β) Between Comet  
Length Values and BT Concentrations 
Donor Without GSH With GSH 
A 0.661 0.751 
B 0.549 0.713 
C 0.692 0.653 
D 0.703 0.658 
E 0.656 0.587 
F 0.668 0.698 
Coefficients are statistically significant (p < 
0.001). 
At least in three donors (A, E, and G), vitamin C (200 μM) alone produced statistically significant 
increases when compared with negative controls. Only donor C showed a significant decrease in basal 
DNA damage after preincubation with vitamin C. As can be seen in Fig. 3, lymphocytes from all donors 
(except donor A) showed a significant vitamin C–related reduction in the level of oxidative damage 
induced by BT and H2O2. This protective effect was seen mainly at 200 μM, but even at 40 μM in some 
cases. 
DISCUSSION 
Measuring increased 8-hydroxy-2'-deoxyguanosine levels, BT was found to be the most effective 
phenolic benzene metabolite inducing oxidative DNA damage when administered alone both in HL-60 
cells in vitro and in mouse bone marrow in vivo[13,32]. It has been suggested that the ability of BT to 
induce apoptosis in human bone marrow progenitor cells may also be involved in benzene 
myelotoxicity[33]. It is known that autoxidation and peroxidative metabolism of the phenolic metabolites 
of benzene produce active oxygen[5], which is capable of causing oxidative DNA lesions and breaks[6,7]. 
In the case of BT, the autoxidation process readily occurs due to its instability and it is enhanced by metal 
ions[9,10,11,13,34]. In a series of studies using HL-60 cells, BT increased superoxide and H2O2 
production, and decreased superoxide dismutase and sulhydryl levels, but not catalase activity[35]. 
With regard to the DNA-binding capacity of quinone and semiquinone radicals produced during BT 
metabolism as one of the proposed mechanisms for BT genotoxicity[1,13], the time dependency of DNA 
adduct formation by BT in HL-60 cells is consistent with the process of BT myeloperoxidative 
activation[36]. In the same study, the authors suggested that the synergistic interaction of benzene 
metabolites in the production of DNA adducts may have significant biological effects. Moreover, for the 
same level of cytotoxicity, BT was found to be a less-effective inducer of DNA adducts than 
hydroquinone, indicating that cellular mechanisms other than adduct formation contribute to the 
cytotoxicity of BT. Similarly, Hedli et al. indicated that the lack of BT-related DNA modification in HL-
60 cells would suggest that DNA adducts not play a role in inhibiting cell differentiation in BT-treated 
cells[37]. According to Lee and coworkers, BT and other benzene metabolites might be able to induce 
DNA strand breaks in living cells without involving DNA adduct formation, by means of the reactive 
oxygen species generated which are also responsible for the inhibitory effect of BT on DNA synthesis, in 
addition to their inhibitory effect on DNA polimerase α[38,39]. 
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FIGURE 1. Mean comet length values for the six donors included in the experiment 1. BT treatments in absence of GSH were 
compared with control values by means of the Mann-Whitney U test (ap < 0.05, bp < 0.01, cp < 0.001). Using the same test, 
DNA damage values in GSH preincubated lymphocytes were compared with values in their parallel nonsupplemented cells (dp 
< 0.05, ep < 0.01, fp < 0.001). 




























(without GSH)    
GSTT1 null 
(with GSH)    
GSTT1 +














FIGURE 2. Mean comet length values in GSTT1 + (A, B, and C) donors compared with those in GSTT1 null (D, 
E, and F) donors. Differences between genotypes are statistically significant (p < 0.001; Mann-Whitney U test) 
both in the absence (a) and presence (b) of GSH. 
In general, BT appears to consistently test positive as a genotoxic agent and it is believed to play some 
role in the genotoxicity observed following benzene exposure. Some studies have shown that BT induces 
alkali-labile sites and DNA breakage, mostly through the generation of oxygen radicals[9,40]. BT also 
induced significant increases in the SCE frequency in human lymphocytes[41] and V79 cells, as well as 
mutations to 6-thioguanine resistance gene[42]. Using an antikinetochore antibody-based micronucleus 
assay and FISH techniques in HL-60 cells, BT was found to produce mainly aneugenic effects by disrupting 
microtubules[13,14]. Moreover, in vitro inhibition of enzymes involved in DNA replication and repair, as 
topoisomerase enzymes, by BT and other benzene metabolites represents a potential mechanism for the 
formation of chromosomal aberrations and may contribute to the leukemogenic effect of benzene[43,44].  
Considering all these data on the cytotoxic and genotoxic effects of BT, and taking into account the 
ability of the alkaline SCGE in detecting oxygen-radical-generated DNA damage, our positive CA results 
were certainly expected and confirmed that BT is able to induce dose-dependent responses in human 
lymphocytes. The DNA-damaging ability of BT was potent enough to be detected in some cases at a 
concentration as low as 5 μM. Specifically, our results are in agreement with those obtained in in vitro 
CA experiments by Anderson et al.[28] and Andreoli et al.[29]. 
Glutathione is one of the most important compounds for maintaining the cellular integrity due to its 
reducing property, which allows it to modulate the redox status of metal ions and other agents and hence 
affect the mode and the rate of reactive oxygen species generation[45]. According to our results, 
preincubating human lymphocytes during 30 min with GSH (350 μg/ml) did not modify the level of BT-
induced DNA damage, indicating that, in this in vitro protocol, GSH does not act as a reductor agent. One 
feasible explanation for this apparent failure of GSH as a protective agent could be that in the presence of 
oxygen, at least for some cell types, GSH is no longer protective, as it has been found in some 
radiosensitivity studies using GSH-deficient cells or GSH-depleted cells[46,47]. Our results are not in 
accordance with previous observations in human bone marrow cells, showing that a similar 30-min 
preincubation with GSH (350 μg/ml, the average human blood concentration) completely blocked the 
DNA damaging effect of benzoquinone and reached a 53% blockage in the case of BT[41]. However, the 
opposite effect was observed in a chemical system, where GSH (1 mM) enhanced the extent of 8-DNA 
double strand breaks induced by hydroquinone, BT and vitamin C[48]. 
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FIGURE 3. Mean tail moment values from combined treatments with BT (25 μM) or H2O2 (20 μM), and vitamin C 
supplementation (0, 40, and 200 μM) for the five donors. BT or H2O2 alone significantly increased DNA damage levels (ap < 
0.001; Mann-Whitney U test). The same test was also used to assess the antioxidant effect of vitamin C (bp < 0.01, cp < 
0.001). 
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In our study, when it was tested alone, vitamin C (200 μM) induced slight, but significant, increases 
in DNA damage, probably acting as an electron donor and accelerating reactive oxygen species 
generation in vitro under aerobic conditions. On the other hand, at the same concentration, acting as a free 
radical scavenger, vitamin C decreased the oxidative DNA damage levels when it was added 30 min 
before BT or H2O2. For the five donors included in the second experiment, the potency of the protective 
effect at 200 μM was calculated as a percentage of damage from unopposed treatments, ranging from 40–
69% and from 27–87% for BT and H2O2, respectively. This in vitro antioxidant effect on H2O2-induced 
DNA damage was also observed by Noroozi et al.[49]. However, using a similar protocol, vitamin C in 
combination with H2O2 had a small protective effect at low doses and exacerbated effects at high 
doses[23]. Applying an ex vivo method, lymphocytes of vitamin C–supplemented subjects showed an 
increase resistance to baseline and induced oxidative damage[50,51]. In addition, vitamin C also affect 
DNA repair[52,53]. 
In the present investigation, responses to BT treatments were somehow consistently reproduced in six 
different donors, although certain differences could be detected when their GSTT1 genotypes were 
considered. In fact, lymphocytes from GSTT1 + subjects seemed to be more sensitive to BT action than 
those from GSTT1 null subjects (i.e., individuals lacking GSTT1 enzyme). This result would be strange or 
at least unexpected because, theoretically, individuals who lack a specific GST enzyme are particularly 
vulnerable to adverse health effects if exposed to its harmful substrates[16,20,54] and GSTs are supposed 
to interact with reactive metabolites in the latest steps of benzene metabolism[1]. It is not clear yet 
whether covalent binding and activation by BT have implications in the regulation of the microsomal 
GST and, since some phenol reactive metabolites might be substrates for the enzyme, their elimination 
through conjugation[55]. Anyway, we recognize that the fact that we have used isolated lymphocytes 
could mislead us to the possible effect of GSTT1 genotype, since the activity of this enzyme is expressed 
mainly in erythrocytes[20,56]. In short, because of the low number of donors, we are not allowed to 
conclude firmly that GSTT1 polymorphism may lead to individual susceptibility differences in the 
genotoxic response to BT, but this observation deserves further investigation and other GST genotypes 
should be also analyzed. 
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